Toll Free: 1-888-928-9744
Published: Feb, 2014 | Pages:
44 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
Chronos Therapeutics Limited - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'Chronos Therapeutics Limited - Product Pipeline Review - 2014', provides an overview of the Chronos Therapeutics Limited's pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Chronos Therapeutics Limited's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Chronos Therapeutics Limited including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Chronos Therapeutics Limited's human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Chronos Therapeutics Limited's pipeline products Reasons to buy - Evaluate Chronos Therapeutics Limited's strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Chronos Therapeutics Limited in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Chronos Therapeutics Limited's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Chronos Therapeutics Limited and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Chronos Therapeutics Limited - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Chronos Therapeutics Limited and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 5 List of Figures 5 Chronos Therapeutics Limited Snapshot 6 Chronos Therapeutics Limited Overview 6 Key Information 6 Key Facts 6 Chronos Therapeutics Limited - Research and Development Overview 7 Key Therapeutic Areas 7 Chronos Therapeutics Limited - Pipeline Review 10 Pipeline Products by Stage of Development 10 Pipeline Products - Monotherapy 11 Chronos Therapeutics Limited - Pipeline Products Glance 12 Chronos Therapeutics Limited - Clinical Stage Pipeline Products 12 Phase I Products/Combination Treatment Modalities 12 Chronos Therapeutics Limited - Early Stage Pipeline Products 13 Preclinical Products/Combination Treatment Modalities 13 Discovery Products/Combination Treatment Modalities 14 Chronos Therapeutics Limited - Drug Profiles 15 RDC-5 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 CHR-1 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 CRH-3 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 CHR-12 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 CHR-25 20 Product Description 20 Mechanism of Action 20 R&D Progress 20 CHR-27 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 CHR-50 22 Product Description 22 Mechanism of Action 22 R&D Progress 22 CHR-54 23 Product Description 23 Mechanism of Action 23 R&D Progress 23 CRH-26 24 Product Description 24 Mechanism of Action 24 R&D Progress 24 CRH-8 25 Product Description 25 Mechanism of Action 25 R&D Progress 25 CRH-9 26 Product Description 26 Mechanism of Action 26 R&D Progress 26 RDC-1 27 Product Description 27 Mechanism of Action 27 R&D Progress 27 RDC-14 28 Product Description 28 Mechanism of Action 28 R&D Progress 28 RDC-19 29 Product Description 29 Mechanism of Action 29 R&D Progress 29 RDC-2 30 Product Description 30 Mechanism of Action 30 R&D Progress 30 RDC-20 31 Product Description 31 Mechanism of Action 31 R&D Progress 31 RDC-21 32 Product Description 32 Mechanism of Action 32 R&D Progress 32 RDC-29 33 Product Description 33 Mechanism of Action 33 R&D Progress 33 RDC-6 34 Product Description 34 Mechanism of Action 34 R&D Progress 34 RDC-7 35 Product Description 35 Mechanism of Action 35 R&D Progress 35 RDC-8 36 Product Description 36 Mechanism of Action 36 R&D Progress 36 RDC-9 37 Product Description 37 Mechanism of Action 37 R&D Progress 37 Chronos Therapeutics Limited - Pipeline Analysis 38 Chronos Therapeutics Limited - Pipeline Products by Target 38 Chronos Therapeutics Limited - Pipeline Products by Molecule Type 39 Chronos Therapeutics Limited - Pipeline Products by Mechanism of Action 40 Chronos Therapeutics Limited - Recent Pipeline Updates 41 Chronos Therapeutics Limited - Locations And Subsidiaries 42 Head Office 42 Appendix 43 Methodology 43 Coverage 43 Secondary Research 43 Primary Research 43 Expert Panel Validation 43 Contact Us 44 Disclaimer 44
List of Tables Chronos Therapeutics Limited, Key Information 6 Chronos Therapeutics Limited, Key Facts 6 Chronos Therapeutics Limited - Pipeline by Indication, 2014 9 Chronos Therapeutics Limited - Pipeline by Stage of Development, 2014 10 Chronos Therapeutics Limited - Monotherapy Products in Pipeline, 2014 11 Chronos Therapeutics Limited - Phase I, 2014 12 Chronos Therapeutics Limited - Preclinical, 2014 13 Chronos Therapeutics Limited - Discovery, 2014 14 Chronos Therapeutics Limited - Pipeline by Target, 2014 38 Chronos Therapeutics Limited - Pipeline by Molecule Type, 2014 39 Chronos Therapeutics Limited - Pipeline Products by Mechanism of Action, 2014 40 Chronos Therapeutics Limited - Recent Pipeline Updates, 2014 41
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.